Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$702.27(as of May 5, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$702.27
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,343
CountyUSA
Market Cap$74,352.9M
EBIDTA4,382.8M
10-Day Moving Average724.67
P/E Ratio17.10
20-Day Moving Average739.41
Forward P/E Ratio15.63
50-Day Moving Average752.49
Earnings per Share41.42
200-Day Moving Average684.24
Profit Margin20.17%
RSI37.89
Shares Outstanding103.0M
ATR20.53
52-Week High820.12
Volume595,737
52-Week Low474.60
Book Value31,423.6M
P/B Ratio2.41
Upper Keltner785.59
P/S Ratio5.07
Lower Keltner693.23
Debt-to-Equity Ratio785.59
Next Earnings DateUnknown
Cash Surplus-2,145.1M
Next Ex-Dividend Date05/20/2026
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of May 06, 2026
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.